当前位置: X-MOL 学术Nat. Rev. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Breast cancer: 10-year follow-up of the TEAM cohort reported
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2017-08-16 , DOI: 10.1038/nrclinonc.2017.133
Peter Sidaway

Follow-up data after 10 years of the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial, in which patients received either exemestrane for 5 years, or tamoxifen followed by exemestane for a total treatment duration of 5 years, confirm the durable efficacy of both approaches. Both groups of

中文翻译:

乳腺癌:TEAM研究组进行了10年的随访

他莫昔芬Exemestane佐剂跨国公司(TEAM)试验10年后的随访数据表明,这两种方法的持久疗效都是持久的,该试验的患者接受了exemestrane治疗5年,或接受他莫昔芬治疗,随后接受exemestane治疗,共5年。两组
更新日期:2017-09-20
down
wechat
bug